Publication | Closed Access

Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α

ThrombosisOleoylethanolamide ProtectsReperfusion InjuryStrokeMedicineNeuropharmacologyBrain InjuryNeuroprotectionNeurologyNeuroscienceCerebral Blood FlowPharmacotherapyPharmacologyIschemic SyndromeOxidative StressNeuroinflammation